comparemela.com

Latest Breaking News On - Aurolife pharma - Page 1 : comparemela.com

Rising Prevalence of Chronic Conditions Drives Global Methadone Market to 2030

Aurobindo Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution USP

Aurobindo Pharma Ltd step-down subsidiary company, Aurolife Pharma LLC., has received a final approval from the US Food & Drug Administration to manufacture and market Diclofenac Sodium Topical Solution USP, 2%.

vimarsana © 2020. All Rights Reserved.